In a landmark development for neurogenetics, a research team led by The Jackson Laboratory (JAX) and the...
Rifan Muazin
In the high-stakes world of pharmaceutical development, where a single Phase 3 clinical trial can represent a...
The global trajectory toward achieving the United Nations’ health-related Sustainable Development Goals (SDGs) is at a critical,...
The landscape of breast cancer treatment is currently undergoing a paradigm shift, moving away from "one-size-fits-all" chemotherapy...
A revolutionary antiviral drug, Hepcludex (bulevirtide-gmod), has achieved a monumental victory in the fight against the Hepatitis...
In the landscape of oncology, few challenges are as persistent as the management of biochemically recurrent (BCR)...
Eli Lilly’s novel oral weight loss medication, Foundayo (orforglipron), has demonstrated significant efficacy in patients aged 65...
Lisbon, Portugal – [Insert Date of Publication] – The Parkinson’s disease (PD) research community is on the...
The landscape of drug discovery is undergoing a seismic shift, moving away from monolithic, single-target approaches toward...
Introduction: A Proposed Paradigm Shift On April 3, the administration released its President’s Budget Request (PBR) for...
